You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment – a review
|
|---|---|
| Published in |
Cardiovascular Diabetology, March 2009
|
| DOI | 10.1186/1475-2840-8-18 |
| Pubmed ID | |
| Authors |
Peter Bramlage, Joerg Hasford |
| Abstract |
Blood pressure lowering drugs are usually evaluated in short term trials determining the absolute blood pressure reduction during trough and the duration of the antihypertensive effect after single or multiple dosing. A lack of persistence with treatment has however been shown to be linked to a worse cardiovascular prognosis. This review explores the blood pressure reduction and persistence with treatment of antihypertensive drugs and the cost consequences of poor persistence with pharmaceutical interventions in arterial hypertension. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 123 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 2% |
| Malaysia | 1 | <1% |
| Turkey | 1 | <1% |
| Spain | 1 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 117 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 21 | 17% |
| Student > Ph. D. Student | 15 | 12% |
| Student > Master | 14 | 11% |
| Student > Doctoral Student | 13 | 11% |
| Other | 11 | 9% |
| Other | 25 | 20% |
| Unknown | 24 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 55 | 45% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 7% |
| Agricultural and Biological Sciences | 5 | 4% |
| Computer Science | 4 | 3% |
| Biochemistry, Genetics and Molecular Biology | 4 | 3% |
| Other | 18 | 15% |
| Unknown | 28 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2021.
All research outputs
#7,960,052
of 25,373,627 outputs
Outputs from Cardiovascular Diabetology
#616
of 1,653 outputs
Outputs of similar age
#36,049
of 107,339 outputs
Outputs of similar age from Cardiovascular Diabetology
#2
of 4 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 1,653 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 107,339 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.